(1) Judd WR, et al. Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa–infected patients. American Journal of Infection Control. June 2016. (http://www.sciencedirect.com/science/article/pii/S0196655316303431);
(2) https://wwwnc.cdc.gov/eid/article/17/10/pdfs/11-0655.pdf;
(3) http://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf